# MitraClip for Severe TR

Study · id `cardio:ct-nct02863549` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02863549](<https://clinicaltrials.gov/study/NCT02863549>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02863549

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02863549. Allocation not applicable; no masking; primary purpose treatment. Start 2016-07 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02863549, source copy `cardio:ctgov-nct02863549-2016-08-11`, retrieved 2026-10-26)
- Start date: 2016-07 (registry gives no type) (ClinicalTrials.gov record NCT02863549, source copy `cardio:ctgov-nct02863549-2016-08-11`, retrieved 2026-10-26)
- Primary completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT02863549, source copy `cardio:ctgov-nct02863549-2016-08-11`, retrieved 2026-10-26)
- Completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT02863549, source copy `cardio:ctgov-nct02863549-2016-08-11`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT02863549, source copy `cardio:ctgov-nct02863549-2016-08-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02863549-2016-08-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: MitraClip for Severe TR
- Acronym: TVrepair
- Condition: Tricuspid Regurgitation
- Intervention (Device): MitraClip in tricuspid valve
- Lead sponsor: LMU Klinikum
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Tricuspid regurgitation (`cardio:tricuspid-regurgitation`)
- Registry lists this organization as the lead sponsor: LMU Klinikum (`cardio:org-lmu-klinikum`)

## Provenance

Content hash: f3e23c4219f672638f8b254c05dba292be32723df965f8da2cbedb92b57e3a72
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
